About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,747 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,747 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2421-2440 of 9,747 trials

CompletedNon-exudative Age-related Macular DegenerationAge-related macular degeneration (AMD) is the most prevalent cause of vision loss in developed countries and is often discussed in terms of the "dry" and the "wet" forms.NCT01712841·Portland, Oregon CompletedRadiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take CisplatinThis phase II/III trial studies how well radiation therapy works with durvalumab or cetuximab in treating patients with head and neck cancer that has spread to a local and/or…NCT03258554·Birmingham, Alabama and 255 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

CompletedDiaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)The study is being conducted to determine if DPS treatment for people with ALS and hypoventilation is associated with improved survival or diaphragm function.NCT01938495·Phoenix, Arizona and 24 others

CompletedAn Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyThe TOPAZ study will assess the safety and efficacy of SRK-015 in later-onset Spinal Muscular Atrophy (SMA Type 2 and Type 3) in pediatric and adult patients.NCT03921528·Phoenix, Arizona and 15 others

CompletedPhase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer TherapiesThis is a 2-arm, randomized, placebo-controlled, double-blind, international, multicenter study comparing the efficacy of ripretinib (DCC-2618) to placebo in patients who have…NCT03353753·Scottsdale, Arizona and 34 others

TerminatedA Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsThe purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as…NCT01905592·Tucson, Arizona and 103 others

CompletedVascular Inflammation in Psoriasis - Extension StudyVIP-E is a one-arm, open-label, 40-52 week extension study to continue or cross over subjects of the VIP study (# 814278) to active drug (adalimumab) to determine if there is…NCT01866592·Sacramento, California and 8 others

CompletedOpen Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease ParticipantsThis is a Phase 2a, multi-center, open-label, two-arm study of approximately 25 patients with active IgG4-related disease (IgG4-RD).NCT04520451·Stanford, California and 8 others

CompletedOxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005837·Birmingham, Alabama and 71 others

CompletedDose-Finding Study of Favipiravir in the Treatment of Uncomplicated InfluenzaThis is a Phase 2, randomized, double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of two doses of favipiravir in adult patients with…NCT01068912·Birmingham, Alabama and 227 others

CompletedClevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)The purpose of this study was to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure \>160…NCT00666328·Washington D.C., District of Columbia and 16 others

CompletedACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.This study will evaluate the efficacy and safety of different durations of treatment with PEGASYS combined with ribavirin in patients with CHC genotype 2 or 3 infection who have…NCT00077636·Birmingham, Alabama and 131 others

TerminatedDose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis PigmentosaThis is an open-label, multiple ascending dose study to evaluate the safety, tolerability, and efficacy of EA-2353 in subjects with RP.NCT05392751·Miami, Florida and 4 others

TerminatedEfficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNETThis study will estimate the treatment effect of everolimus in combination with pasireotide LAR relative to everolimus alone on progression-free survival (PFS) in patients with…NCT01374451·Boston, Massachusetts and 46 others

RecruitingA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsThis is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab…NCT06549595·Huntsville, Alabama and 234 others

CompletedA Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor TreatmentREVERXaL study aims to increase the understanding of the patient characteristics, bleeding presentation, health care interventions provided, and the clinical as well as…NCT06147830·Chandler, Arizona and 74 others

Active not recruitingA Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk MelanomaThis phase II trial studies how pembrolizumab works before and after surgery in treating patients with stage III-IV high-risk melanoma.NCT03698019·Birmingham, Alabama and 814 others

TerminatedA Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) ExpressionNon-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung.NCT04274907·Birmingham, Alabama and 38 others

CompletedMulticenter Study of the Safety and Efficacy of NAFT-500 in Tinea PedisA research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo, when used in subjects with tinea pedis (athlete's foot).NCT00750139·Birmingham, Alabama and 16 others

CompletedEVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory StudyProspective, multicenter, single arm study with consecutive, eligible subject enrollment at each site.NCT03298477·Huntsville, Alabama and 26 others

PreviousPage 122 of 488Next

in Portland

Heart Diseasein Portland